HFSANQXRJIZSJW-GXRBQQLTSA-N Chemical compound HFSANQXRJIZSJW-GXRBQQLTSA-N 0.000 description 3. Assignors: ICOS CORPORATION (A DELAWARE CORPORATION) Adjusted expiration legal-status Critical Status Expired - Lifetime legal-status Critical Current Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Icos Corp filed Critical Icos Corp Priority to US10/758,675 priority Critical patent/US6998416B2/en Publication of US20040152754A1 publication Critical patent/US20040152754A1/en Priority to US11/268,374 priority patent/US7176229B2/en Application granted granted Critical Publication of US6998416B2 publication Critical patent/US6998416B2/en Assigned to ICOS CORPORATION (A WASHINGTON CORPORATION) reassignment ICOS CORPORATION (A WASHINGTON CORPORATION) MERGER (SEE DOCUMENT FOR DETAILS). Original Assignee Icos Corp Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Schlachter Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Lifetime, expires Application number US10/758,675 Other versions US20040152754A1 Google Patents Cyclic AMP-specific phosphodiesterase inhibitorsÄownload PDF Info Publication number US6998416B2 US6998416B2 US10/758,675 US75867504A US6998416B2 US 6998416 B2 US6998416 B2 US 6998416B2 US 75867504 A US75867504 A US 75867504A US 6998416 B2 US6998416 B2 US 6998416B2 Authority US United States Prior art keywords nmr mhz cdcl mmol aryl Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US6998416B2 - Cyclic AMP-specific phosphodiesterase inhibitors US6998416B2 - Cyclic AMP-specific phosphodiesterase inhibitors
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |